Holen Sie sich die Stockscreener-App
0.862
2.35%
-0.0276
Schlusskurs vom Vortag:
$0.8896
Offen:
$0.9
24-Stunden-Volumen:
171.05K
Relative Volume:
0.21
Marktkapitalisierung:
$112.08M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.91M
KGV:
-3.9182
EPS:
-0.22
Netto-Cashflow:
$-19.57M
1W Leistung:
-7.90%
1M Leistung:
-13.99%
6M Leistung:
+1.55%
1J Leistung:
-38.82%
1-Tages-Spanne:
$0.865
$0.907
1-Wochen-Bereich:
$0.8596
$0.9579
52-Wochen-Spanne:
$0.5526
$1.66
Atossa Therapeutics Inc Stock (ATOS) Company Profile
Firmenname
Atossa Therapeutics Inc
Sektor
Branche
Telefon
206.588.0256
Adresse
10202 5TH AVENUE NE, SEATTLE, WA
Vergleichen Sie ATOS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATOS
Atossa Therapeutics Inc
|
0.8677 | 114.91M | 0 | -26.91M | -19.57M | -0.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.97 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
632.67 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.67 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.64 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.94 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-01-26 | Eingeleitet | Maxim Group | Buy |
Atossa Therapeutics Inc Aktie (ATOS) Neueste Nachrichten
Is Atossa Therapeutics Inc. reversing from oversold territoryLong Setup & Entry Point Confirmation Signals - newser.com
Does Atossa Therapeutics Inc. fit your quant trading modelMarket Performance Summary & Long-Term Capital Growth Strategies - newser.com
Is a relief rally coming for Atossa Therapeutics Inc. holdersJuly 2025 Weekly Recap & Stock Portfolio Risk Control - newser.com
Atossa Therapeutics Inc. stock trend outlook and recovery pathMarket Activity Recap & Scalable Portfolio Growth Ideas - newser.com
What earnings revisions data tells us about Atossa Therapeutics Inc.Analyst Downgrade & Community Verified Watchlist Alerts - newser.com
Why Atossa Therapeutics Inc. stock is seen as undervaluedJuly 2025 Retail & Free AI Powered Buy and Sell Recommendations - newser.com
Candlestick signals on Atossa Therapeutics Inc. stock todayEarnings Miss & Low Drawdown Momentum Trade Ideas - newser.com
How Atossa Therapeutics Inc. stock trades before earningsJuly 2025 Setups & High Conviction Investment Ideas - newser.com
How rising interest rates impact Atossa Therapeutics Inc. stockJuly 2025 Big Picture & Risk Managed Investment Entry Signals - newser.com
How Atossa Therapeutics Inc. (YAG2) stock trades after earningsDividend Hike & Accurate Entry/Exit Alerts - newser.com
Is Atossa Therapeutics Inc. stock a smart buy before Fed meetingGlobal Markets & AI Forecast for Swing Trade Picks - newser.com
Is Atossa Therapeutics Inc. stock attractive for income investors2025 Trade Ideas & Verified Short-Term Plans - newser.com
Will Atossa Therapeutics Inc. stock split again soonWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
What moving averages say about Atossa Therapeutics Inc.Quarterly Profit Review & Weekly Breakout Stock Alerts - newser.com
Will Atossa Therapeutics Inc. (YAG2) stock hit analyst forecastsPortfolio Return Report & Weekly Market Pulse Updates - newser.com
Visual analytics tools that track Atossa Therapeutics Inc. performance2025 EndofYear Setup & Free High Return Stock Watch Alerts - newser.com
Atossa Genetics (NASDAQ:ATOS) Share Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Atossa Genetics Inc. (NASDAQ:ATOS) Sees Large Drop in Short Interest - MarketBeat
Applying big data sentiment scoring on Atossa Therapeutics Inc.Portfolio Update Summary & Low Drawdown Trading Strategies - newser.com
Can Atossa Therapeutics Inc. (YAG2) stock reach $200 price target2025 Market Sentiment & Reliable Intraday Trade Alerts - newser.com
Is Atossa Therapeutics Inc. (YAG2) stock inflation resilientJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - newser.com
NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Amarillo Globe-News
Published on: 2025-10-31 05:58:12 - newser.com
What hedge fund moves indicate for Atossa Therapeutics Inc. (YAG2) stockLong Setup & Risk Adjusted Swing Trade Ideas - newser.com
Can Atossa Therapeutics Inc. stock sustain market leadershipJuly 2025 Recap & Capital Efficiency Focused Ideas - newser.com
When is the best time to exit Atossa Therapeutics Inc.2025 Performance Recap & Weekly High Momentum Picks - newser.com
Atossa Therapeutics Inc. stock outlook for YEARJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
Will Atossa Therapeutics Inc. stock benefit from commodity pricesMarket Growth Report & Stepwise Trade Signal Implementation - newser.com
Detecting price anomalies in Atossa Therapeutics Inc. with AIOptions Play & Verified Momentum Stock Watchlist - newser.com
How cyclical is Atossa Therapeutics Inc. (YAG2) stock compared to rivalsJuly 2025 Drop Watch & Community Shared Stock Ideas - newser.com
How high can Atossa Therapeutics Inc. stock goCPI Data & Safe Capital Growth Tips - newser.com
Published on: 2025-10-31 00:04:50 - newser.com
Will Atossa Therapeutics Inc. (YAG2) stock announce a stock splitWeekly Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
Finanzdaten der Atossa Therapeutics Inc-Aktie (ATOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.68%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):